Protagenic Therapeutics I...

NASDAQ: PTIX · Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT

Protagenic Therapeutics Revenue

Protagenic Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Protagenic Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
1
Market Cap
2.54M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Jun 30, 2015 0 n/a
Jun 30, 2014 0 -100.00%
Jun 30, 2013 85K -99.79%
Dec 31, 2010 40.03M -42.07%
Dec 31, 2009 69.09M -39.33%
Dec 31, 2008 113.88M +207.94%
Dec 31, 2007 36.98M +97.54%
Dec 31, 2006 18.72M +Infinity%
Jul 31, 2005 0 n/a
Jul 31, 2004 0 n/a
Jul 31, 2003 0 -100.00%
Jul 31, 2002 18.57M -14.12%
Jul 31, 2001 21.63M +1.11%
Jul 31, 2000 21.39M +13.99%
Jul 31, 1999 18.76M +20.16%
Jul 31, 1998 15.62M +24.19%
Jul 31, 1997 12.57M +27.00%
Jul 31, 1996 9.9M +43.48%
Jul 31, 1995 6.9M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.